AccScience Publishing / GTM / Online First / DOI: 10.36922/gtm.3678
EDITORIAL

Omicron or no longer omicron: That is the question

Giuseppe Lippi1*
Show Less
1 Department of Engineering for Innovative Medicine, Section of Clinical Biochemistry, Faculty of Medicine, University of Verona, Verona, Italy
Global Translational Medicine 2024, 3(2), 3678 https://doi.org/10.36922/gtm.3678
Submitted: 15 May 2024 | Published: 10 June 2024
© 2024 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Conflict of interest
The author declares no conflicts of interest.
References
  1. Bose M, Munshi C. Comparative analysis of immune responses in humans infected with Alpha, Delta, and Omicron strains of SARS-CoV-2. Glob Transl Med. 2024;3:2228. doi: 10.36922/gtm.2228

 

  1. Wang X, Lu L, Jiang S. SARS-CoV-2 evolution from the BA.2.86 to JN.1 variants: Unexpected consequences. Trends Immunol. 2024;45(2):81-84. doi: 10.1016/j.it.2024.01.003

 

  1. Li P, Liu Y, Faraone JN, et al. Distinct patterns of SARS-CoV-2 BA.2.87.1 and JN.1 variants in immune evasion, antigenicity, and cell-cell fusion. mBio. 2024;15(5): e0075124. doi: 10.1128/mbio.00751-24
Share
Back to top
Global Translational Medicine, Electronic ISSN: 2811-0021 Published by AccScience Publishing